For this year’s post-ASCO Lung Cancer panel discussion, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center, and Founder and President of GRACE, Christine Lovly, Associate Professor of Medicine, Division of Hematology-Oncology, and Dr. Alfredo Addeo, Medical Oncologist, department of Oncology at the University Hospital of Geneva (HUG), discuss the most current and emerging treatment information recently presented at ASCO.
Drs. Drs. West, Lovly, and Addeo discuss the ADAURA trial, which studied patients with resected or resectable stage IB-IIIA EGFR+ NSCLC who were given Tagrisso.
In this video, Drs. West, Lovly, and Addeo discuss the ADAURA trial, which studied patients with resected or resectable stage IB-IIIA EGFR+ NSCLC who were given Tagrisso.
For more, please visit http://cancerGRACE.org/.
To join the conversation, visit https://cancergrace.org/forum.
Sound Used: Once Again (BenSound.com)
License #: 2LN6RROJA08RATWY